↓ Skip to main content

Recombinant interleukin 2 therapy in severe combined immunodeficiency disease.

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, July 1989
Altmetric Badge

Mentioned by

patent
5 patents

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Recombinant interleukin 2 therapy in severe combined immunodeficiency disease.
Published in
Proceedings of the National Academy of Sciences of the United States of America, July 1989
DOI 10.1073/pnas.86.13.5069
Pubmed ID
Authors
Abstract

Severe combined immunodeficiency disease (SCID) is a congenital disorder of severe B- and T-lymphocyte dysfunction in which several pathogenic mechanisms have been identified. The present study describes a female child with SCID who had a primary defect in the ability of T cells to secrete interleukin 2 (IL-2). B- and T-cell numbers were normal, but their functions were severely deficient. Mitogen and antigen-driven lymphoproliferative responses were diminished but were correctable in vitro with recombinant IL-2 (rIL-2). The patient's phytohemagglutinin-stimulated lymphocytes expressed IL-2 receptors normally. Despite the presence of the gene for IL-2, the patient's cells were grossly deficient in messenger RNA for IL-2 and endogenous IL-2 production. Pokeweed mitogen-driven B-cell differentiation was decreased and was not corrected by the addition of normal T cells to the B cells. Two attempts at immune reconstitution by haploidentical bone marrow transplantation failed. Therapy with rIL-2 (30,000 units/kg, given daily i.v.) resulted in marked clinical improvement as well in improved T-cell functions. The child, now 3 yr old, has been on rIL-2 therapy for 2 yr and receives rIL-2 (30,000 units/kg) three times weekly at home. This case study points to a new direction in the treatment of such disorders with rIL-2.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 1 8%
Netherlands 1 8%
Indonesia 1 8%
Unknown 9 75%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 4 33%
Other 2 17%
Researcher 2 17%
Professor 1 8%
Student > Master 1 8%
Other 0 0%
Unknown 2 17%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 3 25%
Medicine and Dentistry 3 25%
Immunology and Microbiology 2 17%
Chemical Engineering 1 8%
Biochemistry, Genetics and Molecular Biology 1 8%
Other 0 0%
Unknown 2 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 August 2009.
All research outputs
#12,425,845
of 34,518,147 outputs
Outputs from Proceedings of the National Academy of Sciences of the United States of America
#83,878
of 119,104 outputs
Outputs of similar age
#7,642
of 20,848 outputs
Outputs of similar age from Proceedings of the National Academy of Sciences of the United States of America
#200
of 319 outputs
Altmetric has tracked 34,518,147 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 119,104 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.1. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 20,848 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 319 others from the same source and published within six weeks on either side of this one. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.